381 References 387. Lividini A, Pizza F, Filardi M, Vandi S, Ingravallo F, Antelmi E, et al. Narcolepsy type 1 features across the life span: age impact on clinical and polysomnographic phenotype. J Clin Sleep Med. 2021;17(7):1363-70. 388. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361(20):1945-52. 389. Yang J, Lau YC, Wu P, Feng L, Wang X, Chen T, et al. Variation in Influenza B Virus Epidemiology by Lineage, China. Emerg Infect Dis. 2018;24(8):1536-40. 390. Karageorgopoulos DE, Vouloumanou EK, Korbila IP, Kapaskelis A, Falagas ME. Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. PLoS One. 2011;6(7):e21690. 391. Hoa LNM, Sullivan SG, Mai LQ, Khvorov A, Phuong HVM, Hang NLK, et al. Influenza A(H1N1)pdm09 But Not A(H3N2) Virus Infection Induces Durable Seroprotection: Results From the Ha Nam Cohort. J Infect Dis. 2022;226(1):59-69. 392. Horby P, Mai le Q, Fox A, Thai PQ, Thi Thu Yen N, Thanh le T, et al. The epidemiology of interpandemic and pandemic influenza in Vietnam, 2007-2010: the Ha Nam household cohort study I. Am J Epidemiol. 2012;175(10):1062-74. 393. Schwahn AB, Downard KM. Proteotyping to establish the lineage of type A H1N1 and type B human influenza virus. J Virol Methods. 2011;171(1):117-22. 394. Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol. 2020;11:587380. 395. Kornum BR. Narcolepsy type 1: what have we learned from immunology? Sleep. 2020;43(10). 396. McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006;3(8):e297. 397. Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev. 2012;11(10):754-65. 398. van der Heide A, Hegeman-Kleinn IM, Peeters E, Lammers GJ, Fronczek R. Immunohistochemical screening for antibodies in recent onset type 1 narcolepsy and after H1N1 vaccination. J Neuroimmunol. 2015;283:58-62. 399. Tanaka S, Honda Y, Inoue Y, Honda M. Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy. Sleep. 2006;29(5):633-8. 400. Overeem S, Verschuuren JJ, Fronczek R, Schreurs L, den Hertog H, HegemanKleinn IM, et al. Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy. J Neuroimmunol. 2006;174(1-2):187-91. 401. Knudsen S, Mikkelsen JD, Jennum P. Antibodies in narcolepsy-cataplexy patient serum bind to rat hypocretin neurons. Neuroreport. 2007;18(1):77-9. 402. Black JL, 3rd, Silber MH, Krahn LE, Avula RK, Walker DL, Pankratz VS, et al. Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602positive narcoleptic subjects with cataplexy. Biol Psychiatry. 2005;58(6):504-9. 403. Black JL, 3rd, Krahn LE, Pankratz VS, Silber M. Search for neuron-specific and nonneuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602. Sleep. 2002;25(7):719-23. 404. Cvetkovic-Lopes V, Bayer L, Dorsaz S, Maret S, Pradervand S, Dauvilliers Y, et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest. 2010;120(3):713-9. 405. Toyoda H, Tanaka S, Miyagawa T, Honda Y, Tokunaga K, Honda M. AntiTribbles homolog 2 autoantibodies in Japanese patients with narcolepsy. Sleep. 2010;33(7):875-8. 12
RkJQdWJsaXNoZXIy MjY0ODMw